HIFU vs observation for low-grade cervical precancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial compares two approaches for women with a low-grade cervical precancer (LSIL) and a high-risk HPV infection. Half of the participants will receive a focused ultrasound treatment (HIFU) to the cervix, and the other half will be carefully watched without treatment. The goal is to see if HIFU helps the abnormal cells go away faster than observation alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older who is still having menstrual periods (pre-menopausal).
- You have a low-grade cervical abnormality (LSIL or CIN1) confirmed by biopsy, and a positive test for high-risk HPV.
- You are not pregnant or breastfeeding.
- You have not had treatment for cervical precancer or cancer before.
- You can attend two follow-up visits after the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows women with an early abnormal cervix cell change (CIN2/CIN2-3) to see how HPV DNA “integration” relates to whether the condition improves or worsens. It may help doctors better predict prognosis and guide safer monitoring, especially if you want to become pregnant.
This trial tests whether an HPV vaccine (the nonavalent type) can help prevent the same precancerous lesions from coming back after treatment. It is for people who currently have a high-grade HPV-related lesion but have not yet been treated for it.
This trial studies whether a high-intensity focused ultrasound treatment can help people with localized prostate cancer while still avoiding traditional full-dose treatment for some patients. It may be an option for certain intermediate-risk cases where the cancer is confined to the prostate.
This observational study looks at outcomes after people choose HIFU (high-intensity focused ultrasound) to treat only a targeted area of the prostate. It may help doctors better understand how well HIFU works and what follow-up imaging or testing shows over time.
This study collects data on men with early, low-risk prostate cancer who choose to have a targeted ultrasound treatment called HIFU (High-Intensity Focused Ultrasound). It looks at how well this treatment works and how men recover.
This study compares different ways to analyze ultrasound images in real time while treating localized prostate cancer with HIFU (a focused ultrasound treatment). It aims to improve how safely and accurately the treatment is monitored.
Hear when a new HPV Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.